Author's posts
Kaiser to cut 64 jobs in California
Okland, Calif.-based Kaiser Permanente shared plans to lay off 64 California employees by April 25, according to multiple WARN notices.
Jefferson CEO sees 'strong headwinds' for healthcare
Philadelphia-based Jefferson Health has grown into a 33-hospital health system after the acquisition of Lehigh Valley Health Network in August 2024 and is now among the top 10 nonprofit health systems in the U.S.
Health systems building Epic tools
As health systems seek to optimize their EHR, many are developing their own tools within their Epic systems to meet specific needs.
The burden of physician turnover in 11 numbers
The potential cost for filling a physician position can top $500,000 when accounting for loss in potential billings and the money needed to recruit to that position, according to a March 4 AMN Healthcare white paper.
HCA's highest-earning executives in 2024
In 2024, HCA Healthcare’s CEO Sam Hazen saw his overall compensation increase by more than $2 million as the health system reported an operating income of $8.5 billion (12.1% operating margin) on revenues of $70.6 billion, according to a proxy statemen…
16 recent revenue cycle executive moves
Memorial Hermann and Rush University System for Health are among the health systems that have recently made revenue cycle leadership hires.
Hospitals targeted with extortion letters
There have been multiple reports to the American Hospital Association and the FBI of hospitals and health systems receiving data extortion letters.
Days cash on hand at 35 health systems
As health systems continue to grapple with financial pressures from rising labor and supply costs and reimbursement challenges, days cash on hand remains an important measure of financial stability.
ASHP partners with ShiftRx on pharmacy workforce staffing
The American Society of Health-System Pharmacists has partnered with ShiftRx, a staffing and workforce management platform, to help address critical shortages in the pharmacy workforce.
FDA scolds drugmaker for 'false or misleading' claims
The FDA has reprimanded Dexcel and its affiliate Edenbridge Pharmaceuticals for “false or misleading” promotional claims regarding its brand-name drug Hemady.
